Reality check: should we try to detect and isolate vancomycin-resistant enterococci patients?
Antimicrobial resistance, including vancomycin resistance in enterococci (VRE), is a growing problem in healthcare facilities. This "Reality Check" session focused on the question of whether we should try to detect and isolate patients colonized or infected with VRE.
Ostrowsky
B
B
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, United States Department of Health and Human Services, Atlanta, Georgia, USA.
Steinberg
J T
JT
Farr
B
B
Sohn
A H
AH
Sinkowitz-Cochran
R L
RL
Jarvis
W R
WR
D001291:Attitude of Health Personnel; D002487:Centers for Disease Control and Prevention, U.S.; D003428:Cross Infection / Q000517:prevention & control*; D016984:Enterococcus faecium / Q000187:drug effects*; D019983:Guideline Adherence; D006801:Humans; D017053:Infection Control / Q000379:methods / Q000592:standards*; D010356:Patient Isolation; D011159:Population Surveillance; D013211:Staphylococcus aureus / Q000187:drug effects; D014481:United States; D020713:Vancomycin Resistance